Arora M, Arora R, Tiwari S C, Das N, Srivastava L M
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi.
Lupus. 2000;9(2):127-31. doi: 10.1191/096120300678828154.
This study assessed the expression of complement receptor 1 (CR1), decay accelerating factor (DAF) and membrane inhibitor of reactive lysis (CD59) on the erythrocytes and glomerulus of diffuse proliferative glomerulonephritis (DPGN) of systemic lupus erythematosus (SLE) patients using flow cytometry and immunofluorescence techniques to elucidate their role in the pathogenesis of DPGN. Expression of CR1 on the erythrocytes and glomerulus of DPGN patients was reduced compared with expression in normal subjects. However, expression of DAF and CD59 was increased on both erythrocytes and glomerulus of DPGN patients, suggesting the generation of a protective response against complement-mediated injury.
本研究采用流式细胞术和免疫荧光技术,评估系统性红斑狼疮(SLE)患者弥漫性增殖性肾小球肾炎(DPGN)的红细胞和肾小球上补体受体1(CR1)、衰变加速因子(DAF)和反应性溶解膜抑制因子(CD59)的表达,以阐明它们在DPGN发病机制中的作用。与正常受试者相比,DPGN患者红细胞和肾小球上CR1的表达降低。然而,DPGN患者的红细胞和肾小球上DAF和CD59的表达均增加,提示机体产生了针对补体介导损伤的保护性反应。